组合口服避孕药改变了外周血液细胞中的核核糖酶和腺氨酸脱氨酶活动
Bruna Pache Moreschi1,2, Romário da Silva Portilho1,2, Andreza Negreli Santos1,3
1Biochemistry Sector, Institute of Biosciences, Federal University of Mato Grosso Do Sul (UFMS), Campo Grande, Mato Grosso Do Sul, 79070-900, Brazil.
Purinergic signalling
|February 26, 2025
概括
荷尔蒙避孕药改变了纯性乙酶的活性,影响了血液静止. 这可能会通过影响腺水平和酶功能来增加血栓栓塞事件的风险.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
背景情况:
- 荷尔蒙避孕药被广泛使用,但与血栓塞栓症有关.
- 纯能介质对于调节血静至关重要.
- 像E-NTPDase,E-5'-NT和E-ADA这样的生体酶是纯能信号传递的关键参与者.
研究的目的:
- 研究使用组合口服避孕药的妇女的淋巴细胞和血小板中的ectoenzymes (E-NTPDase,E-5'-NT,E-ADA) 的活性.
- 探索使用荷尔蒙避孕药与纯能介质代谢变化之间的关系.
- 评估这些酶变化与血栓栓塞事件风险之间的潜在联系.
主要方法:
- 对淋巴细胞和血小板进行了酶活性测试.
- 参与者使用了第三代 (3G) 或第四代 (4G) 联合口服避孕药.
- 在避孕药使用者和对照组之间比较了酶活性.
主要成果:
- 使用3G避孕药的女性显示,淋巴细胞中的腺胺去除显著降低,血小板中的AMP水解和腺胺去除显著降低.
- 使用4G避孕药的妇女在淋巴细胞中显著减少了腺胺去除,并减少了血小板中的ATP水解和腺胺去除.
- 这些发现表明缺乏腺的血管微环境和降低抗血小板/抗炎作用.
结论:
- 荷尔蒙避孕药显著改变了纯激素外酶的活性.
- 观察到的酶活性变化可能导致血液静止的改变.
- 这些变化可能与对血栓栓塞事件的倾向性增加有关.
相关概念视频
01:14Time Course of Drug Effect
1.9K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.9K
01:28Adrenergic Agonists: Mixed-Action Agents
651
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
651
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:18Effects of EDTA on End-Point Detection Methods
239
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a...
239
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
700
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
700
01:22Dose-Response Relationship: Potency and Efficacy
4.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.1K